ArticlePLoS neglected tropical diseases2025
Trichinella spiralis serine protease mediates larval invasion of gut epithelium via binding to CK8 and activating RhoA/ROCK1 pathway.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Vaccination of mice with Trichinella spiralis serine proteinase enhanced gut epithelial barrier and elicited a high protective immunity.PLoS neglected tropical diseases · 2026Article
- A Trichinella spiralis Trypsin Drives Macrophage M1 Polarization and Strengthens Cytotoxicity Killing Larvae via Activating the NF-κB Pathway.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTrichinella spiralis adult worms and larvae parasitize respectively in small intestine and skeletal muscles of the same host, and larval invasion of gut mucosa is the pivotal step for T. spiralis infection. A T. spiralis serine proteinase (TsSPc) was identified in its intestinal infective larva (IIL) ES antigens. TsSPc is involved in larval invasion of gut epithelium, but the mechanism is not completely elucidated. The purpose of this study was to investigate the mechanism of TsSPc action in larval invasion of gut mucosa. METHODOLOGY/PRINCIPAL FINDING: The results of molecular docking, immunofluorescence assay (IFA), GST pull-down and co-immunoprecipitation (Co-IP) showed that rTsSPc specifically bound to cytokeratin 8 (CK8) receptor in Caco-2 cells and activated RhoA/ROCK1 signaling pathway, as demonstrated by the evidently increased expression levels of CK8, RhoA and ROCK1. The results of qPCR and Western blot analysis revealed that binding of rTsSPc with CK8 and activation of RhoA/ROCK1 pathway significantly decreased the expression levels of gut epithelial tight junctions (TJs, E-cad, Occludin and Claudin-1), and increased the paracellular permeability. Knocking down CK8 in Caco-2 cells and ROCK1 pathway inhibitor Y27632 obviously inhibited the activation of RhoA/ROCK1 pathway, abolished rTsSPc-decreased TJs expression, rTsSPc-increased paracellular permeability, and inhibited larval invasion of Caco-2 monolayers in vitro. When the mice were pretreated with CK8 inhibitor Dasatinib and ROCK1 pathway inhibitor Y27632, and then orally infected with T. spiralis larvae, the activation of CK8 and RhoA/ROCK1 was significantly suppressed, intestinal permeability and adult worm burdens were obviously decreased, and intestinal inflammation was also distinctly alleviated. The number of intestinal goblet cells, expression of mucins (Muc2 and Muc5ac) and inflammatory cytokines (IL-1β, TNF-α, IL-10 and TGF-β) were significantly reduced.
conclusionsTsSPc binding to CK8 receptor in gut epithelium activated RhoA/ROCK1 pathway, reduced TJs expression and disrupted gut epithelial integrity, therefore mediated larval invasion of host gut mucosa. TsSPc might be considered as a promising vaccine molecular target for intercepting T. spiralis invasion and infection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.